








































Over the last couple of decades, gender dysphoria 
has gradually become more apparent, which has led to 
an increasing focus on transgender health research.1,2 
It is estimated that 355/100,000 individuals consider 
themselves transgender and 9.2/100,000 would undergo 
gender-affirming therapy.2 This gender-affirming therapy 
comprises holistic treatment regimens with several non-
surgical and surgical interventions, including genitouri-
nary reconstruction.
In transmen, phalloplasty is considered the stan-
dard treatment option for genitourinary reconstruction, 
particularly in patients desiring both sexual function and 
the ability to void while standing.1,3,4 However, phalloplasty 
procedures entail a remarkably high risk for complica-
tions, especially at the level of the neourethra.1 Apart from 
urethral fistulas, which have been reported in up to 75% 
after phalloplasty, urethral stricture formation represents 
another important complication with incidence rates of 
25%–58%.1 These urethral strictures can occur through-
out the entire length of the neourethra, although the 
anastomosis between the fixed and phallic part seems to 
be the most affected site.1,3
Despite these high incidence rates of urethral stric-
ture formation after phalloplasty, only scarce data about 
its management have been reported and the available evi-
dence is merely based on small, retrospective series with 
very heterogeneous patient cohorts.3,5–8 In 2011, Lumen 
et al3 described the largest patient series about urethro-
plasty after phallic reconstruction and analyzed the out-
come of different techniques. Based on that experience, 
the authors made several treatment recommendations 
and advised to treat isolated, short (≤3.0 cm), anastomotic 
strictures with excision and primary anastomosis (EPA).3 
However, since that treatment recommendation, there 
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Background: Since the recommendation to perform excision and primary anas-
tomosis (EPA) for isolated, short, anastomotic strictures in transmen, there have 
been no further reports about its results. This study aims to provide an updated 
and extended report about the results of EPA for the aforementioned indication.
Methods: Since 2002, data of all transmen in whom an EPA urethroplasty has been 
performed at Ghent University Hospital were collected in a database. Exclusion 
criteria for this analysis were age <18 years old, nonanastomotic strictures, and 
stricture length >3.0 cm. Postoperative complications were analyzed with descrip-
tive statistics. Failure-free survival (FFS) was analyzed with Kaplan–Meier statistics. 
Need for further urethral manipulation was used as definition for failure. Potential 
predictors for failure were entered in a univariate Cox regression analysis.
Results: In total, 44 patients were included with a median (interquartile range) 
follow-up of 40 months (7–125 months). Complications after EPA urethroplasty 
were present in 12 (27%) of the patients and mainly involved low-grade complica-
tions (11/44, 25%). After 1, 2, and 5 years, the estimated FFS rate (SD) was 61% 
(7.8), 61% (7.8), and 47% (9.1). Stricture length (hazard ratio [HR], 2.11; P = 
0.03), prior urethroplasty (HR, 3.53; P = 0.008), and extravasation at first voiding 
cystourethrography (HR, 3.00; P = 0.047) were identified as predictors for failure.
Conclusions: EPA for an isolated, short, anastomotic stricture in transmen is associ-
ated with low complication rates, but high failure rates. After 5 years, the estimated 
FFS rate is 47%. Stricture length, prior urethroplasty, and extravasation at first 
voiding cystourethrography are predictors for failure. (Plast Reconstr Surg Glob Open 
2020;8:e2641; doi: 10.1097/GOX.0000000000002641; Published online 6 February 2020.)
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have been no reports about the experience with this tech-
nique in this particular patient subgroup.
Against this background, the aim of this study is to pro-
vide an updated and extended report about the results of 
EPA for an isolated, short (≤3.0 cm), anastomotic stricture 
after phalloplasty in transmen.
MATERIALS AND METHODS
Patients
Since 2002, data of all transmen in whom an EPA 
urethroplasty has been performed at Ghent University 
Hospital were collected in a database. Since 2008, data 
were collected prospectively. This database contains 
extensive information about patient, stricture, phal-
loplasty, and perioperative characteristics. Surgery was 
performed by two surgeons (P.H. and N.L.). Patients <18 
years old, patients with nonanastomotic strictures, and 
patients with strictures >3.0 cm were excluded from this 
analysis. Informed consent was obtained from all included 
patients, and the study was approved by the local ethics 
committee (UZG2008/234).
Creation of the Fixed Part of the Neourethra
In all patients, the fixed part of the neourethra was 
created in a standardized fashion in which the vestibu-
lar mucosa was tubularized around a transurethral drain 
(18Fr) up to the level of the clitoris. Afterwards, the clito-
ris and fixed part of the neourethra were tunneled toward 
the prepubic incision and the clitoris was sutured on the 
periost of the pubic bone.
Preoperative Work-up
Urethral stricture diagnosis was confirmed by ure-
thrography, which also allowed assessment of stricture 
location and length. Thereafter, patients were planned 
for urethroplasty ≥3 months after phalloplasty and the 
latest transurethral intervention. In case of urinary 
retention, urinary derivation was ensured by a suprapu-
bic catheter or perineostomy. One week preoperatively, 
patients were instructed to deliver a urine sample for uri-
nary culture. In case of urinary tract infection, adequate 
antibiotics were started 24 hours before surgery and con-
tinued postoperatively. Otherwise, a single intravenous 
shot of cefazolin was routinely administered at the start 
of the operation.
Treatment Algorithm
At Ghent University Hospital, transmen presenting 
with an anastomotic stricture ≤3.0 cm were initially man-
aged by one attempt of direct vision internal urethrotomy 
(DVIU), provided that there was no complete oblitera-
tion. In case of complete obliteration or failure of DVIU, 
EPA urethroplasty was performed.
Surgical Technique
Patients were installed in a standard lithotomy posi-
tion (Fig.  1). A straight beniqué was inserted through 
the phallic meatus up to the stricture. Then, a transverse 
skin incision was made over the scar line at the base of 
the neophallus and dissection was pursued through the 
subcutaneous fat tissue. Thereafter, the stricture was lon-
gitudinally opened on the tip of the beniqué and further 
exposed through a bilateral stay suture. A 3Fr ureteral 
catheter was inserted through the created opening and 
moved up proximally, through the strictured area. Then, 
the stricture was further opened on this ureteral catheter 
up to the point of a normal urethral caliber. In patients 
with a perineostomy, the introduction of a second beni-
qué through the urethrostomy aids in identifying the 
proximal extent of the stricture, which is very helpful in 
case of a complete obliteration. Subsequently, the entire 
strictured segment was excised and both healthy urethral 
ends were spatulated. Thereafter, the phallic urethral end 
was mobilized until enough length was gained for anasto-
motic repair. The spatulated ends were anastomosed with 
interrupted resorbable 4.0 sutures over a 16Fr urethral 
catheter and the wound was closed in layers.
Postoperative Course and Follow-up
Patients were discharged from the hospital with the 
transurethral catheter in place. Generally, 14 days post-
operatively, a pericatheter voiding cystourethrography 
(VCUG) was performed and in absence of contrast extrav-
asation, the transurethral catheter was removed. In case 
of contrast extravasation, the transurethral catheter was 
maintained and a new VCUG was performed 1 week later.
Patients were followed after 3, 6, and 12 months and 
annually thereafter. Follow-up visits included history tak-
ing, physical examination, and uroflowmetry. In case of 
obstructive symptoms or a maximal flow rate <15 mL/s, 
additional urethroscopy and/or urethrography was 
performed.
Statistical Analysis
Baseline and perioperative characteristics were ana-
lyzed using descriptive statistics. Stricture length was 
recorded as measured peroperatively. Postoperative 
(<90 d) complications were categorized according to 
Clavien–Dindo.9 Failure-free survival (FFS) was ana-
lyzed using Kaplan–Meier statistics. Herein, patients 
were censored at the moment of latest follow-up or at 
the time of death. A functional definition of failure was 
used: “stricture recurrence at the site of reconstruction 
warranting additional urethral intervention(s), includ-
ing simple dilation.”9 Potential predictors for failure 
were entered in a univariate Cox regression analysis. 
All statistical tests were 2-sided, and P values <0.05 were 
considered statistically significant. Analyses were per-
formed using SPSS 25.0.
RESULTS
In total, 44 patients were included in this study. Median 
[interquartile range (IQR)] follow-up was 40 months (7–
125 mo). Baseline characteristics are represented in Table 1. 
Median (IQR) stricture length was 1.0 cm (1.0–1.1 cm), 
and most patients (28/44, 64%) underwent prior urethral 
interventions. The radial-free forearm flap phalloplasty 
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(35/44, 80%) with a radial free forearm flap tube-in-tube 
neourethra (33/44, 75%) was the most common type of 
phalloplasty procedure. Wound or flap complications after 
phalloplasty were present in 41 (93%) patients and mainly 
involved wound dehiscence (21/44, 48%) or flap necro-
sis (18/44, 41%). The median (IQR) interval between the 
phalloplasty and the EPA urethroplasty was 10 months (6–22 
mo). As additional analysis, the number of strictures >1.0 cm 
was compared between the different degrees of wound/
flap complication after phalloplasty, but no statistically sig-
nificant differences were found: 4/21 (19%) after wound 
dehiscence, 4/13 (31%) after partial flap necrosis, and 0/5 
(0%) after complete flap necrosis (P = 0.4).
Perioperative characteristics are represented in 
Table  2. A complete obliteration was present in 18/34 
(53%) patients with available data and 11/44 (25%) 
procedures involved concomitant fistula repair. Median 
(IQR) hospital and catheter stay were respectively 1 day 
(1–2 d) and 14 days (10–17 d). In 8 (20%) patients, there 
was contrast extravasation at the first postoperative VCUG. 
Complications after EPA urethroplasty were present in 
12 (27%) patients and mainly involved low-grade com-
plications [urinary tract infection (3/44, 6.8%), wound 
infection (3/44, 6.8%), hematoma (2/44, 4.5%), reten-
tion (4/44, 9.1%), and fistula (5/44, 11%)]. In 1 patient 
(2.3%), urinary retention required the placement of a 
suprapubic catheter.
In total, 19/44 (43%) procedures failed. After 1, 2, and 
5 years, the estimated FFS rate (SD) was 61% (7.8), 61% 
(7.8), and 47% (9.1) (Fig. 2).
Stricture length [hazard ratio (HR), 2.11; P = 0.03], 
prior urethroplasty (HR, 3.53; P = 0.008), and extrava-
sation at first VCUG (HR, 3.00; P = 0.047) were identi-
fied as predictors for urethroplasty failure (Table 3). As 
Fig. 1. Surgical technique. A, Skin incision at the base of the neophallus. B, Exposure of the surgical field with a Lone Star retractor and 
opening of the stricture on the tip of the beniqué. C, Further opening the stricture on the ureteral catheter. D, Resection of the entire stric-
tured urethral segment. E, Mobilization of the phallic urethral end. F, Tension-free end-to-end anastomosis of the spatulated urethral ends.
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additional analysis, success rates were plotted against stric-
ture length and showed lower success in longer strictures 
with 0% success rate in strictures >2.0 cm (Fig. 3).
DISCUSSION
The aim of this study was to report the results of EPA 
for isolated, short, anastomotic strictures after phallic 
reconstruction in transmen, as there have been no reports 
about this since its recommendation in 2011.3 To the best 
of our knowledge, this is the first study that scrutinizes the 
outcome of one particular urethroplasty technique in a 
homogeneous transmen patient cohort. The results are 
noteworthy and—in our opinion—of utmost importance 
for daily clinical practice.
Even though EPA represents a straightforward proce-
dure with relatively low complication rates, it led to an 
important number of failures in this patient cohort. The 
5-year FFS estimate was only 47%, a substantially inferior 
result compared with the 93% composite success rate 
after EPA in native males.10 This discrepancy might be 
explained by a multitude of factors, all related to the dif-
ferences between a neophallus and a native penis. First 
of all, the environment to perform a urethral recon-
struction in is much poorer after phalloplasty because 
it consists of heavily operated tissues with a very tenuous 
Table 1. Baseline Characteristics
Total (n = 44)
Median follow-up, mo (IQR) 40 (7–125)
Patient characteristics
 Median age, y (IQR) 31 (23–40)
 Comorbidities, n (%)  
  Smoking or cessation <1 y 3 (7.2)
  Cardiovascular disease 0 (0)
  Diabetes 1 (2.3)
Stricture characteristics
 Median stricture length, cm (IQR) 1.0 (1.0–1.1)
 Concomitant fistula, n (%) 11 (25)
 Prior urethral interventions, n (%)  
  None 16 (36)
  1 DVIU/dilation 7 (16)
  >1 DVIU/dilation 4 (9.1)
  Urethroplasty ± DVIU/dilation 17 (39)
Phalloplasty characteristics
 Type of phalloplasty, n (%)  
  RFFF 35 (80)
  ALT 9 (21)
 Type of neourethra n (%)  
  RFFF tube-in-tube 33 (75)
  ALT tube-in-tube 5 (11)
  Pedicled SCIAP flap 5 (11)
  Free SCIAP flap 0 (0)
  Other 1 (2.3)
 Prior metoidioplasty, n (%) 6 (14)
 Wound/flap complications, n (%)  
  None 3 (6.8)
  Wound dehiscence at the base 21 (48)
  Partial flap necrosis 13 (30)
  Complete flap necrosis 5 (11)
  Venous congestion 2 (4.5)
ALT, anterolateral thigh; RFFF, radial free forearm flap; SCIAP, superficial cir-
cumflex iliac artery perforator.
Table 2. Perioperative Characteristics
Total (n = 44)
UTI, n (%) 1 (2.3)
Preoperative urinary diversion, n (%)  
 None 27 (61)
 Suprapubic catheter 5 (11)
 Perineostomy 12 (27)
Complete obliteration, n (%)  
 No 16 (36)
 Yes 18 (41)
 Missing 10 (23)
Peroperative fistula repair, n (%) 11 (25)
Closure of the perineostomy, n (%)  
 No 1 (2.3)
 Yes, immediate closure 9 (21)
 Yes, delayed closure 2 (4.5)
Median operation time, min (IQR) 63 (49–80)
Median hospital stay, d (IQR) 1 (1–2)
Median catheter stay, d (IQR) 14 (10–17)
Extravasation at first VCUG, n (%) 8 (20)
Postoperative complications (Clavien–Dindo), n (%)  
 None 32 (73)
 Grade 1 5 (11)
 Grade 2 6 (14)
 Grade 3 1 (2.3)
UTI, urinary tract infection.
Fig. 2. Failure-free survival after excision and primary anastomosis 
for a short, anastomotic stricture in transmen.
Table 3. Univariate Cox Regression Analysis
HR (95% CI) P
Surgeon 0.92 (0.33–2.59) 0.9
Age 0.97 (0.92–1.02) 0.2
Stricture length 2.11 (1.09–4.09) 0.03
Concomitant fistula 0.48 (0.14–1.67) 0.5
Prior urethroplasty 3.53 (1.38–9.01) 0.008
Type of phalloplasty 0.50 (0.12–2.16) 0.4
Type of neourethra 1.27 (0.87–1.88) 0.2
Wound/flap complication  
after phalloplasty
 
 None (reference) Reference ref.
 Wound dehiscence 0.46 (0.05–4.25) 0.5
 Partial flap necrosis 1.60 (0.18–14.45) 0.7
 Complete flap necrosis 1.18 (0.07–18.00) 0.9
UTI 0.41 (0.06–2.62) 0.3
Preoperative urinary diversion 0.92 (0.32–2.62) 0.9
Operation time 1.00 (0.98–1.02) 0.8
Extravasation at first VCUG 3.00 (1.02–8.86) 0.047
P values < 0.05 are highlighted in bold.
UTI, urinary tract infection.
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vascularization.1,3,4 Also, local wound healing problems 
and other complications after phallic reconstruction can 
lead to extensive fibrotic tissue, which further impedes 
the vascularization and complicates any reconstructive 
procedure at the neourethra.3 Another explanation lies 
within the fact that the anastomosis between the fixed 
and phallic part of the neourethra is in fact a mucocu-
taneous junction and therefore prone to stricture for-
mation.3,11 After EPA, the strictured segment is indeed 
completely excised, but the new anastomosis remains a 
mucocutaneous junction and thus at risk for restricture 
formation. A third element that possibly explains the 
different outcome of EPA in transmen is represented by 
the differences in elasticity of a neourethra and a bulbar 
urethra of a native male. It is a well-known fact that a ten-
sion-free anastomosis is imperative for success after EPA, 
and, therefore, it is of utmost importance that both ure-
thral ends can be mobilized sufficiently.10 In the bulbar 
urethra, a gap of 2.5 cm can be bridged after thorough 
mobilization of both urethral ends, given its estimated 
length and elasticity of respectively 10 cm and 25%.11–13 
On the other hand, a neourethra is much more resistant 
to mobilization and extensive skeletonization of the phal-
lic urethral end could in turn lead to ischemia of the anas-
tomosis and threaten the outcome of the operation.4 In 
our opinion, residual tension at the anastomosis is one of 
the main factors contributing to failure after EPA, also in 
our patient cohort, and especially in those with a higher 
stricture length. In these cases, it should be advised to 
switch to an alternative treatment strategy rather than 
forcing an end-to-end anastomosis.
In the univariate Cox regression analysis, stricture 
length, prior urethroplasty, and extravasation at first 
VCUG were identified as predictors for failure in this par-
ticular patient cohort. As described above, it makes sense 
that longer strictures are harder to treat with EPA: lon-
ger gaps require more mobilization and entail the risk of 
ischemia and residual tension at the anastomosis.4 Based 
on this and the additional analysis, it should be advised 
not to perform EPA for strictures >2.0 cm and to only use 
it if a tension-free anastomosis can be obtained without 
excessive skeletonization. Second, prior urethroplasty 
implicates further scarring of the area to reconstruct 
and further deteriorates the vascular environment for 
EPA. Finally, as regards extravasation of contrast at the 
first VCUG, this could reflect the presence of a techni-
cal flaw or the presence of ischemia at the urethral ends. 
Considering this, it can be expected that these cases are 
particularly at risk for stricture recurrence, especially early 
after surgery.
The rather disappointing results of this study under-
line the importance of mitigating the risk of postphal-
loplasty stricture formation because these strictures are 
extremely challenging to treat. So far, it has been estab-
lished that the use of periurethral or paravaginal tissue 
flaps is to be preferred to create the neourethra because 
they are associated with the lowest risk of stricture forma-
tion.4 Also, it has been documented that preserving the 
vaginal cavity leads to more neourethral complications, 
and, therefore, a vaginectomy should be performed when-
ever possible.4 Other studies have looked into the added 
value of gracilis flaps4,8 and prelaminated neourethras,4,12 
although the true benefit of these modifications remains 
unclear and prelamination has even been associated to an 
extremely high stricture rate (88%) in a recent publica-
tion.14 Given this background, it is clear that more studies 
about risk-lowering strategies will be needed to optimize 
the complex treatment of this unique patient popula-
tion. Furthermore, considering the suboptimal results of 
EPA for this indication, all patients should be counseled 
accordingly and future research should look into better 
alternatives. Based on the data of Lumen et al,3 it could be 
deducted that a 2-stage repair would be a valuable alter-
native, given its lower stricture recurrence rates (30%), 
Fig. 3. Success rate according to stricture length.
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although prospective, homogeneous data will be required 
to fully support this hypothesis.3 Another possibility could 
be to perform a DVIU which entails a success rate of 
about 50%.15 However, many of our patients underwent 
prior urethral interventions and a substantial number of 
them had a complete obliteration, which makes a DVIU 
impossible.
This study contains several limitations. Before 2008, all 
data were collected retrospectively, which implicates the 
risks of bias. Also, a functional definition of failure was 
used, whereas an anatomical definition could have led to 
more and earlier “failures.”16 However, to date, there is no 
consensus about the true or most appropriate definition 
of failure after urethroplasty.17 The lack of functional data 
forms another limitation, although no patient-reported 
outcome measures have been validated for this specific 
patient population. Finally, the limited sample size may be 
considered a limitation as well, although this study rep-
resents the largest homogeneous transmen patient series 
so far that investigates the outcome of one particular ure-
throplasty technique for one particular indication.
CONCLUSIONS
EPA for an isolated, short, anastomotic stricture after 
phalloplasty in transmen is associated with low complica-
tion rates, but high failure rates. After 5 years, the estimated 
FFS rate is 47%. Stricture length, prior urethroplasty, and 
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